European Psychiatry: Volume 15 - Congress of the Association of European Psychiatrists

European Psychiatry

Only show content I have access to (976)

Over 3 years (976)

View selected items
Save to my bookmarks
Export citations
Download PDF (zip)
Save to Kindle
Save to Dropbox
Save to Google Drive
Save content to
To save this undefined to your undefined account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your undefined account. Find out more about saving content to .

To save this article to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Please be advised that item(s) you selected are not available.
You are about to save
European Psychiatry
ISSN: 0924-9338

EISSN: 1778-3585

URL: /core/journals/european-psychiatry
Your Kindle email address

Please provide your Kindle email.

@free.kindle.com @kindle.com (service fees apply)

By using this service, you agree that you will only keep content for personal use, and will not openly distribute them via Dropbox, Google Drive or other file sharing services

European Psychiatry

Refine listing

Actions for selected content:

Congress of the Association of European Psychiatrists

SES14. AEP Section “Psychopharmacology”: From receptor pharmacology to clinical prescription

Symposia

SES14.05 Transnosological Prescription

W06. Mednet schizophrenia - a German research network

Symposia

W06.01 Concept, Structure, and Function of the German Research Network On Schizophrenia

W06.03 New Pharmacological Treatment Strategies: Acute First Episode Schizophrenia, Non-response and Predominant Negative Symptoms

W06.02 Early Detection and Intervention in Populations at Risk

W06.04 Long-term Treatment of First Episode Schizophrenia: New Strategies, Prodromal Symptoms and Biological Basis of Relapse

W08. Prevention of addiction: programme for elementary and high school pupils

Symposia

W08.03 The Planning and Implementation of Primary Prevention Programmes in Schools. Evidence Based Reconsideration

W08.02 Early Prevention of Drug Abuse: Methodological and Conceptual Considerations

W06. Mednet schizophrenia - a German research network

Symposia

W06.05 New Strategies in Prevention and Rehabilitation of Residual Schizophrenia

W06.06 Molecular-genetic Predictors of Illness Manifestation, Course, and Treatment Response

W08. Prevention of addiction: programme for elementary and high school pupils

Symposia

W08.01 An educational program for the prevention of drug abuse in a high - school

W08.04 Methodological and ethical limitations of school based addiction prevention

FC10. Social outcomes of mental disorders

Symposia

FC10.02 Deinstitutionalisation, Living Situation and Subjective Satisfaction of Schizophrenic Patients

FC10.01 Outcome of Patients with Severe Mental Illness and Borderline Intellectual Functioning

FC10.03 A Contolled Clinical Trial of Intensive Home Treatment for Persons with Severe Mental Illness

FC10.04 Social Disability in Schizophrenia: Its Development and Prediction Over 15 Years in Incidence Cohorts in Six European Centres

FC10.05 Do Community Based Mental Health Care Networks Neglect Mentally Ill Homeless People?

FC10.06 What is a Psychiatrist? What are They Really Doing? A Qualitative Study Combining Focus Groups and Work Sampling

DE03. The old neuroleptics are becoming obsolete (Supported by Pfizer)

Symposia

DE03.01 Should-second Generation Antipsychotics be Favored Over Traditional Neuroleptics in the Treatment of Patients With Schizophrenia?

DE03.02 Contra

SES15. AEP Section “Torture and Persecution”: Diversity and unity: sequels to persecution and torture

Symposia

SES15.03 Treatment Services for Survivors of Torture: A Transcultural Study

European Psychiatry

Refine listing

Actions for selected content:

Save Search

Congress of the Association of European Psychiatrists

SES14. AEP Section “Psychopharmacology”: From receptor pharmacology to clinical prescription

Symposia

W06. Mednet schizophrenia - a German research network

Symposia

W08. Prevention of addiction: programme for elementary and high school pupils

Symposia

W06. Mednet schizophrenia - a German research network

Symposia

W08. Prevention of addiction: programme for elementary and high school pupils

Symposia

FC10. Social outcomes of mental disorders

Symposia

DE03. The old neuroleptics are becoming obsolete (Supported by Pfizer)

Symposia

SES15. AEP Section “Torture and Persecution”: Diversity and unity: sequels to persecution and torture

Symposia